Quality returns alpha
Willem Vinke draws comparisons between the European and Global strategies and their respective benchmarks, identifying sources of alpha.
Generating alpha through the recovery
Willem Vinke describes expectations of an imminent and strong economic recovery.
Strong recovery on the horizon
Willem Vinke discusses economic recovery, inflation risks and overpriced stocks.
Value rotation continues
Willem Vinke discusses how the Funds are prepared for when economies reopen.
Encouraging global outlook
Willem Vinke reflects on the short and long-term global outlook and the potential impact on the Funds.
Vaccines and political stability
Willem Vinke discusses the political stability following the roll out of vaccines.
Maintaining a defensive strategy
Willem Vinke tilts the European portfolio towards more cyclical and value names given political developments, vaccines and further stimulus.
A tilt to cyclical and value stocks
Willem Vinke discusses the adjustments made to portfolio allocation in light of recent political developments and the news of a vaccine.
Picking quality investments during volatility
Willem Vinke continues to hold a defensive position with a preference to companies that should endure market volatility.
A continued focus on quality
Willem Vinke invests in high quality companies that we believe will be better placed to endure future market volatility.
Willem Vinke reflects on July’s performance, noting caution as he looks at current levels of economic and political risk.
The stimulus cushion
Willem Vinke reasons that the true economic impact has yet to be realised due to the intervention of central banks and governments.